Center for American Progress offers plan to improve Medicare

The Center for American Progress has put forward a proposal to make changes within Medicare aimed at helping users, including instituting consumer-friendly ratings of the benefits new drugs may have, limiting what patients must pay for new drugs and requiring pharmaceutical companies to disclose how much is actually spent on researching and bringing new drugs to market, the Associated Press said. Read More »

Immune Pharmaceuticals signs licensing agreement for AmiKet

Immune Pharmaceuticals, Inc., said Monday it entered into a definitive license and research agreement with Yissum to license some Yissum's patents for the development and commercialization of a topical nano-formulated version of AmiKet. AmiKet, a topical drug for the treatment of neuropathic pain, has undergone trials involving more than 1,700 patients demonstrating comparable effectiveness to the high dose of the oral standard of care, gabapentin in a double-blind, placebo-controlled Phase II c Read More »